nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—prostate cancer	0.222	0.563	CbGaD
Perphenazine—CYP2C18—prostate cancer	0.0991	0.252	CbGaD
Perphenazine—AOX1—Ethinyl Estradiol—prostate cancer	0.058	0.157	CbGbCtD
Perphenazine—CYP2C19—prostate cancer	0.0444	0.113	CbGaD
Perphenazine—AOX1—Estradiol—prostate cancer	0.0374	0.101	CbGbCtD
Perphenazine—CYP3A4—prostate cancer	0.0283	0.0719	CbGaD
Perphenazine—CYP2C8—Nilutamide—prostate cancer	0.0158	0.0427	CbGbCtD
Perphenazine—CYP2C19—Nilutamide—prostate cancer	0.0133	0.0358	CbGbCtD
Perphenazine—CYP2C19—Bicalutamide—prostate cancer	0.0133	0.0358	CbGbCtD
Perphenazine—CYP2C8—Abiraterone—prostate cancer	0.0131	0.0354	CbGbCtD
Perphenazine—CYP2B6—Estrone—prostate cancer	0.0125	0.0338	CbGbCtD
Perphenazine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0122	0.033	CbGbCtD
Perphenazine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0111	0.0301	CbGbCtD
Perphenazine—CYP2C9—Nilutamide—prostate cancer	0.011	0.0298	CbGbCtD
Perphenazine—CYP2C9—Bicalutamide—prostate cancer	0.011	0.0298	CbGbCtD
Perphenazine—CYP2C19—Flutamide—prostate cancer	0.011	0.0297	CbGbCtD
Perphenazine—CYP1A2—Flutamide—prostate cancer	0.0101	0.0274	CbGbCtD
Perphenazine—CYP2D6—Bicalutamide—prostate cancer	0.0101	0.0272	CbGbCtD
Perphenazine—CYP2C8—Cabazitaxel—prostate cancer	0.00969	0.0262	CbGbCtD
Perphenazine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00844	0.0228	CbGbCtD
Perphenazine—CYP2D6—Abiraterone—prostate cancer	0.00836	0.0226	CbGbCtD
Perphenazine—CYP1A2—Estrone—prostate cancer	0.00733	0.0198	CbGbCtD
Perphenazine—CYP2C9—Estrone—prostate cancer	0.00661	0.0179	CbGbCtD
Perphenazine—CYP3A4—Bicalutamide—prostate cancer	0.00641	0.0173	CbGbCtD
Perphenazine—HTR7—vas deferens—prostate cancer	0.00625	0.174	CbGeAlD
Perphenazine—CYP3A4—Estramustine—prostate cancer	0.00596	0.0161	CbGbCtD
Perphenazine—CYP2C8—Estradiol—prostate cancer	0.00544	0.0147	CbGbCtD
Perphenazine—CYP3A4—Flutamide—prostate cancer	0.00531	0.0144	CbGbCtD
Perphenazine—CYP3A4—Abiraterone—prostate cancer	0.00531	0.0144	CbGbCtD
Perphenazine—CYP2C9—Capecitabine—prostate cancer	0.00501	0.0135	CbGbCtD
Perphenazine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0048	0.013	CbGbCtD
Perphenazine—CYP2C19—Estradiol—prostate cancer	0.00456	0.0123	CbGbCtD
Perphenazine—CYP1A2—Estradiol—prostate cancer	0.00421	0.0114	CbGbCtD
Perphenazine—CYP3A4—Cabazitaxel—prostate cancer	0.00393	0.0106	CbGbCtD
Perphenazine—CYP2C19—Prednisone—prostate cancer	0.00392	0.0106	CbGbCtD
Perphenazine—CYP3A4—Estrone—prostate cancer	0.00384	0.0104	CbGbCtD
Perphenazine—CYP2C9—Estradiol—prostate cancer	0.00379	0.0103	CbGbCtD
Perphenazine—CYP2C8—Etoposide—prostate cancer	0.00355	0.0096	CbGbCtD
Perphenazine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00342	0.00925	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—prostate cancer	0.0032	0.00864	CbGbCtD
Perphenazine—CYP1A2—Etoposide—prostate cancer	0.00275	0.00743	CbGbCtD
Perphenazine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00251	0.00679	CbGbCtD
Perphenazine—CALM2—semen—prostate cancer	0.00229	0.0639	CbGeAlD
Perphenazine—CYP3A4—Mitoxantrone—prostate cancer	0.00228	0.00617	CbGbCtD
Perphenazine—CALM1—semen—prostate cancer	0.00228	0.0636	CbGeAlD
Perphenazine—CYP3A4—Estradiol—prostate cancer	0.00221	0.00596	CbGbCtD
Perphenazine—CYP3A4—Prednisone—prostate cancer	0.0019	0.00513	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—prostate cancer	0.00155	0.00418	CbGbCtD
Perphenazine—CYP2C19—urine—prostate cancer	0.00152	0.0424	CbGeAlD
Perphenazine—CYP3A4—Etoposide—prostate cancer	0.00144	0.00389	CbGbCtD
Perphenazine—CYP3A4—Docetaxel—prostate cancer	0.00132	0.00356	CbGbCtD
Perphenazine—CYP1A2—urine—prostate cancer	0.00124	0.0346	CbGeAlD
Perphenazine—CYP2C9—urine—prostate cancer	0.00118	0.0329	CbGeAlD
Perphenazine—CYP3A4—Doxorubicin—prostate cancer	0.000983	0.00265	CbGbCtD
Perphenazine—HTR2A—urine—prostate cancer	0.00097	0.0271	CbGeAlD
Perphenazine—CYP3A4—urine—prostate cancer	0.000898	0.0251	CbGeAlD
Perphenazine—CYP2D6—urine—prostate cancer	0.000883	0.0247	CbGeAlD
Perphenazine—AOX1—prostate gland—prostate cancer	0.000812	0.0227	CbGeAlD
Perphenazine—CALM3—prostate gland—prostate cancer	0.000731	0.0204	CbGeAlD
Perphenazine—AOX1—seminal vesicle—prostate cancer	0.000687	0.0192	CbGeAlD
Perphenazine—CALM3—seminal vesicle—prostate cancer	0.000618	0.0173	CbGeAlD
Perphenazine—CALM2—prostate gland—prostate cancer	0.000574	0.016	CbGeAlD
Perphenazine—CALM1—prostate gland—prostate cancer	0.000571	0.0159	CbGeAlD
Perphenazine—AOX1—renal system—prostate cancer	0.000553	0.0154	CbGeAlD
Perphenazine—AOX1—urethra—prostate cancer	0.000544	0.0152	CbGeAlD
Perphenazine—CALM3—urethra—prostate cancer	0.000489	0.0137	CbGeAlD
Perphenazine—CALM2—seminal vesicle—prostate cancer	0.000486	0.0136	CbGeAlD
Perphenazine—CALM2—epithelium—prostate cancer	0.000422	0.0118	CbGeAlD
Perphenazine—CALM1—epithelium—prostate cancer	0.00042	0.0117	CbGeAlD
Perphenazine—HRH1—prostate gland—prostate cancer	0.000417	0.0116	CbGeAlD
Perphenazine—HTR7—epithelium—prostate cancer	0.00041	0.0114	CbGeAlD
Perphenazine—ADRA2A—prostate gland—prostate cancer	0.000409	0.0114	CbGeAlD
Perphenazine—HTR1A—renal system—prostate cancer	0.000398	0.0111	CbGeAlD
Perphenazine—CALM2—renal system—prostate cancer	0.000391	0.0109	CbGeAlD
Perphenazine—CALM1—renal system—prostate cancer	0.00039	0.0109	CbGeAlD
Perphenazine—CALM2—urethra—prostate cancer	0.000384	0.0107	CbGeAlD
Perphenazine—CALM1—urethra—prostate cancer	0.000383	0.0107	CbGeAlD
Perphenazine—HTR7—renal system—prostate cancer	0.000381	0.0106	CbGeAlD
Perphenazine—CALM3—bone marrow—prostate cancer	0.000377	0.0105	CbGeAlD
Perphenazine—AOX1—testis—prostate cancer	0.000358	0.00998	CbGeAlD
Perphenazine—ADRA2A—seminal vesicle—prostate cancer	0.000346	0.00966	CbGeAlD
Perphenazine—CYP2C8—renal system—prostate cancer	0.000324	0.00905	CbGeAlD
Perphenazine—CALM3—testis—prostate cancer	0.000322	0.00899	CbGeAlD
Perphenazine—HRH1—epithelium—prostate cancer	0.000306	0.00855	CbGeAlD
Perphenazine—CYP1A2—renal system—prostate cancer	0.000303	0.00847	CbGeAlD
Perphenazine—CALM2—bone marrow—prostate cancer	0.000296	0.00826	CbGeAlD
Perphenazine—CALM1—bone marrow—prostate cancer	0.000295	0.00822	CbGeAlD
Perphenazine—CYP2B6—renal system—prostate cancer	0.000291	0.00812	CbGeAlD
Perphenazine—HRH1—urethra—prostate cancer	0.000279	0.00779	CbGeAlD
Perphenazine—ADRA2A—urethra—prostate cancer	0.000274	0.00765	CbGeAlD
Perphenazine—AOX1—lymph node—prostate cancer	0.000259	0.00723	CbGeAlD
Perphenazine—HTR2A—epithelium—prostate cancer	0.000256	0.00714	CbGeAlD
Perphenazine—CALM2—testis—prostate cancer	0.000253	0.00706	CbGeAlD
Perphenazine—CALM1—testis—prostate cancer	0.000252	0.00702	CbGeAlD
Perphenazine—HTR7—testis—prostate cancer	0.000246	0.00686	CbGeAlD
Perphenazine—HTR2A—renal system—prostate cancer	0.000237	0.00662	CbGeAlD
Perphenazine—CALM3—lymph node—prostate cancer	0.000233	0.00651	CbGeAlD
Perphenazine—DRD2—testis—prostate cancer	0.000233	0.00649	CbGeAlD
Perphenazine—CYP3A4—renal system—prostate cancer	0.00022	0.00613	CbGeAlD
Perphenazine—CYP2D6—renal system—prostate cancer	0.000216	0.00603	CbGeAlD
Perphenazine—CYP2C8—testis—prostate cancer	0.00021	0.00585	CbGeAlD
Perphenazine—CYP2B6—testis—prostate cancer	0.000188	0.00525	CbGeAlD
Perphenazine—HRH1—testis—prostate cancer	0.000184	0.00512	CbGeAlD
Perphenazine—CALM2—lymph node—prostate cancer	0.000183	0.00512	CbGeAlD
Perphenazine—CALM1—lymph node—prostate cancer	0.000182	0.00509	CbGeAlD
Perphenazine—ADRA2A—testis—prostate cancer	0.00018	0.00503	CbGeAlD
Perphenazine—HTR2A—testis—prostate cancer	0.000153	0.00428	CbGeAlD
Perphenazine—CYP2D6—testis—prostate cancer	0.00014	0.0039	CbGeAlD
Perphenazine—HRH1—lymph node—prostate cancer	0.000133	0.00371	CbGeAlD
Perphenazine—ADRA2A—lymph node—prostate cancer	0.000131	0.00365	CbGeAlD
Perphenazine—Domperidone—CYP3A5—prostate cancer	0.000113	0.0631	CrCbGaD
Perphenazine—Acepromazine—SLC22A1—prostate cancer	0.000105	0.0586	CrCbGaD
Perphenazine—Thioproperazine—SLC22A1—prostate cancer	0.000103	0.0573	CrCbGaD
Perphenazine—Pipotiazine—SLC22A1—prostate cancer	0.000101	0.0563	CrCbGaD
Perphenazine—Thiothixene—SLC22A1—prostate cancer	0.000101	0.0563	CrCbGaD
Perphenazine—Nefazodone—CYP3A5—prostate cancer	9.42e-05	0.0524	CrCbGaD
Perphenazine—Aripiprazole—CYP3A5—prostate cancer	8.76e-05	0.0487	CrCbGaD
Perphenazine—Trazodone—CYP3A5—prostate cancer	8.72e-05	0.0485	CrCbGaD
Perphenazine—Clomipramine—GSTP1—prostate cancer	8.65e-05	0.0481	CrCbGaD
Perphenazine—Hypersensitivity—Goserelin—prostate cancer	7.24e-05	0.000783	CcSEcCtD
Perphenazine—Infection—Mitoxantrone—prostate cancer	7.21e-05	0.000779	CcSEcCtD
Perphenazine—Hypersensitivity—Conjugated Estrogens—prostate cancer	7.17e-05	0.000775	CcSEcCtD
Perphenazine—Shock—Mitoxantrone—prostate cancer	7.14e-05	0.000772	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—prostate cancer	7.11e-05	0.000769	CcSEcCtD
Perphenazine—Muscle spasms—Etoposide—prostate cancer	7.11e-05	0.000769	CcSEcCtD
Perphenazine—Agranulocytosis—Capecitabine—prostate cancer	7.11e-05	0.000768	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—prostate cancer	7.09e-05	0.000766	CcSEcCtD
Perphenazine—Tachycardia—Mitoxantrone—prostate cancer	7.08e-05	0.000766	CcSEcCtD
Perphenazine—Hypoglycaemia—Epirubicin—prostate cancer	7.05e-05	0.000763	CcSEcCtD
Perphenazine—Insomnia—Estradiol—prostate cancer	7.04e-05	0.000762	CcSEcCtD
Perphenazine—Hypoaesthesia—Docetaxel—prostate cancer	7.03e-05	0.00076	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—prostate cancer	7.03e-05	0.00076	CcSEcCtD
Perphenazine—Bradycardia—Capecitabine—prostate cancer	6.96e-05	0.000752	CcSEcCtD
Perphenazine—Oedema peripheral—Docetaxel—prostate cancer	6.96e-05	0.000752	CcSEcCtD
Perphenazine—Pruritus—Goserelin—prostate cancer	6.95e-05	0.000751	CcSEcCtD
Perphenazine—Dyspnoea—Estradiol—prostate cancer	6.94e-05	0.000751	CcSEcCtD
Perphenazine—Somnolence—Estradiol—prostate cancer	6.92e-05	0.000749	CcSEcCtD
Perphenazine—Anorexia—Mitoxantrone—prostate cancer	6.92e-05	0.000748	CcSEcCtD
Perphenazine—Pruritus—Conjugated Estrogens—prostate cancer	6.89e-05	0.000744	CcSEcCtD
Perphenazine—Hyperglycaemia—Prednisone—prostate cancer	6.86e-05	0.000742	CcSEcCtD
Perphenazine—Hypoaesthesia—Capecitabine—prostate cancer	6.8e-05	0.000735	CcSEcCtD
Perphenazine—Hypotension—Mitoxantrone—prostate cancer	6.78e-05	0.000733	CcSEcCtD
Perphenazine—Decreased appetite—Estradiol—prostate cancer	6.77e-05	0.000732	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—prostate cancer	6.75e-05	0.00073	CcSEcCtD
Perphenazine—Oedema peripheral—Capecitabine—prostate cancer	6.73e-05	0.000728	CcSEcCtD
Perphenazine—Diarrhoea—Goserelin—prostate cancer	6.72e-05	0.000727	CcSEcCtD
Perphenazine—Constipation—Estradiol—prostate cancer	6.66e-05	0.00072	CcSEcCtD
Perphenazine—Pain—Estradiol—prostate cancer	6.66e-05	0.00072	CcSEcCtD
Perphenazine—Diarrhoea—Conjugated Estrogens—prostate cancer	6.66e-05	0.00072	CcSEcCtD
Perphenazine—Leukopenia—Etoposide—prostate cancer	6.62e-05	0.000716	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—prostate cancer	6.58e-05	0.000712	CcSEcCtD
Perphenazine—Cardiac arrest—Epirubicin—prostate cancer	6.55e-05	0.000708	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—prostate cancer	6.53e-05	0.000706	CcSEcCtD
Perphenazine—Loss of consciousness—Etoposide—prostate cancer	6.5e-05	0.000703	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—prostate cancer	6.5e-05	0.000703	CcSEcCtD
Perphenazine—Dizziness—Goserelin—prostate cancer	6.5e-05	0.000702	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—prostate cancer	6.47e-05	0.0007	CcSEcCtD
Perphenazine—Dyspnoea—Mitoxantrone—prostate cancer	6.47e-05	0.000699	CcSEcCtD
Perphenazine—Cough—Etoposide—prostate cancer	6.45e-05	0.000698	CcSEcCtD
Perphenazine—Somnolence—Mitoxantrone—prostate cancer	6.45e-05	0.000698	CcSEcCtD
Perphenazine—Dizziness—Conjugated Estrogens—prostate cancer	6.44e-05	0.000696	CcSEcCtD
Perphenazine—Convulsion—Etoposide—prostate cancer	6.41e-05	0.000693	CcSEcCtD
Perphenazine—Hypertension—Etoposide—prostate cancer	6.39e-05	0.00069	CcSEcCtD
Perphenazine—Decreased appetite—Mitoxantrone—prostate cancer	6.31e-05	0.000682	CcSEcCtD
Perphenazine—Orthostatic hypotension—Epirubicin—prostate cancer	6.29e-05	0.00068	CcSEcCtD
Perphenazine—Pain—Mitoxantrone—prostate cancer	6.21e-05	0.000671	CcSEcCtD
Perphenazine—Constipation—Mitoxantrone—prostate cancer	6.21e-05	0.000671	CcSEcCtD
Perphenazine—Bradycardia—Prednisone—prostate cancer	6.2e-05	0.00067	CcSEcCtD
Perphenazine—Urticaria—Estradiol—prostate cancer	6.19e-05	0.000669	CcSEcCtD
Perphenazine—Body temperature increased—Estradiol—prostate cancer	6.16e-05	0.000666	CcSEcCtD
Perphenazine—Headache—Goserelin—prostate cancer	6.15e-05	0.000665	CcSEcCtD
Perphenazine—Erythema—Docetaxel—prostate cancer	6.15e-05	0.000665	CcSEcCtD
Perphenazine—Headache—Conjugated Estrogens—prostate cancer	6.1e-05	0.000659	CcSEcCtD
Perphenazine—Confusional state—Etoposide—prostate cancer	6.09e-05	0.000658	CcSEcCtD
Perphenazine—Muscular weakness—Epirubicin—prostate cancer	6.07e-05	0.000656	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—prostate cancer	6.06e-05	0.000655	CcSEcCtD
Perphenazine—Anaphylactic shock—Etoposide—prostate cancer	6.04e-05	0.000653	CcSEcCtD
Perphenazine—Infection—Etoposide—prostate cancer	6e-05	0.000648	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—prostate cancer	5.99e-05	0.000648	CcSEcCtD
Perphenazine—Erythema—Capecitabine—prostate cancer	5.95e-05	0.000643	CcSEcCtD
Perphenazine—Asthma—Epirubicin—prostate cancer	5.95e-05	0.000643	CcSEcCtD
Perphenazine—Dysphagia—Epirubicin—prostate cancer	5.95e-05	0.000643	CcSEcCtD
Perphenazine—Muscle spasms—Docetaxel—prostate cancer	5.91e-05	0.000639	CcSEcCtD
Perphenazine—Tachycardia—Etoposide—prostate cancer	5.89e-05	0.000637	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—prostate cancer	5.89e-05	0.000637	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—prostate cancer	5.82e-05	0.000629	CcSEcCtD
Perphenazine—Alimemazine—CYP3A4—prostate cancer	5.78e-05	0.0321	CrCbGaD
Perphenazine—Urticaria—Mitoxantrone—prostate cancer	5.77e-05	0.000623	CcSEcCtD
Perphenazine—Anorexia—Etoposide—prostate cancer	5.75e-05	0.000622	CcSEcCtD
Perphenazine—Hypersensitivity—Estradiol—prostate cancer	5.74e-05	0.00062	CcSEcCtD
Perphenazine—Body temperature increased—Mitoxantrone—prostate cancer	5.74e-05	0.00062	CcSEcCtD
Perphenazine—Muscle spasms—Capecitabine—prostate cancer	5.72e-05	0.000619	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—prostate cancer	5.65e-05	0.000611	CcSEcCtD
Perphenazine—Hypotension—Etoposide—prostate cancer	5.64e-05	0.00061	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—prostate cancer	5.62e-05	0.000607	CcSEcCtD
Perphenazine—Vision blurred—Capecitabine—prostate cancer	5.61e-05	0.000606	CcSEcCtD
Perphenazine—Pipotiazine—CYP2C19—prostate cancer	5.56e-05	0.0309	CrCbGaD
Perphenazine—Syncope—Docetaxel—prostate cancer	5.51e-05	0.000596	CcSEcCtD
Perphenazine—Pruritus—Estradiol—prostate cancer	5.51e-05	0.000596	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—prostate cancer	5.51e-05	0.000595	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—prostate cancer	5.51e-05	0.000595	CcSEcCtD
Perphenazine—Leukopenia—Docetaxel—prostate cancer	5.5e-05	0.000595	CcSEcCtD
Perphenazine—Chlorpromazine—SLC22A1—prostate cancer	5.49e-05	0.0305	CrCbGaD
Perphenazine—Quetiapine—CYP3A5—prostate cancer	5.48e-05	0.0305	CrCbGaD
Perphenazine—Eosinophilia—Doxorubicin—prostate cancer	5.45e-05	0.000589	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—prostate cancer	5.43e-05	0.000587	CcSEcCtD
Perphenazine—Loss of consciousness—Docetaxel—prostate cancer	5.4e-05	0.000584	CcSEcCtD
Perphenazine—Dyspnoea—Etoposide—prostate cancer	5.38e-05	0.000582	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—prostate cancer	5.37e-05	0.00058	CcSEcCtD
Perphenazine—Somnolence—Etoposide—prostate cancer	5.37e-05	0.00058	CcSEcCtD
Perphenazine—Cough—Docetaxel—prostate cancer	5.36e-05	0.00058	CcSEcCtD
Perphenazine—Hypersensitivity—Mitoxantrone—prostate cancer	5.35e-05	0.000578	CcSEcCtD
Perphenazine—Syncope—Capecitabine—prostate cancer	5.34e-05	0.000577	CcSEcCtD
Perphenazine—Diarrhoea—Estradiol—prostate cancer	5.33e-05	0.000576	CcSEcCtD
Perphenazine—Leukopenia—Capecitabine—prostate cancer	5.33e-05	0.000576	CcSEcCtD
Perphenazine—Convulsion—Docetaxel—prostate cancer	5.33e-05	0.000576	CcSEcCtD
Perphenazine—Hypertension—Docetaxel—prostate cancer	5.31e-05	0.000574	CcSEcCtD
Perphenazine—Drowsiness—Epirubicin—prostate cancer	5.31e-05	0.000574	CcSEcCtD
Perphenazine—Erythema—Prednisone—prostate cancer	5.3e-05	0.000573	CcSEcCtD
Perphenazine—Decreased appetite—Etoposide—prostate cancer	5.25e-05	0.000567	CcSEcCtD
Perphenazine—Loss of consciousness—Capecitabine—prostate cancer	5.23e-05	0.000566	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—prostate cancer	5.23e-05	0.000565	CcSEcCtD
Perphenazine—Cough—Capecitabine—prostate cancer	5.19e-05	0.000561	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—prostate cancer	5.17e-05	0.000559	CcSEcCtD
Perphenazine—Constipation—Etoposide—prostate cancer	5.16e-05	0.000558	CcSEcCtD
Perphenazine—Pain—Etoposide—prostate cancer	5.16e-05	0.000558	CcSEcCtD
Perphenazine—Dizziness—Estradiol—prostate cancer	5.15e-05	0.000557	CcSEcCtD
Perphenazine—Hypertension—Capecitabine—prostate cancer	5.14e-05	0.000556	CcSEcCtD
Perphenazine—Dry mouth—Docetaxel—prostate cancer	5.12e-05	0.000553	CcSEcCtD
Perphenazine—Confusional state—Docetaxel—prostate cancer	5.06e-05	0.000547	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—prostate cancer	5.03e-05	0.000543	CcSEcCtD
Perphenazine—Anaphylactic shock—Docetaxel—prostate cancer	5.02e-05	0.000542	CcSEcCtD
Perphenazine—Vision blurred—Prednisone—prostate cancer	5e-05	0.00054	CcSEcCtD
Perphenazine—Infection—Docetaxel—prostate cancer	4.98e-05	0.000539	CcSEcCtD
Perphenazine—Mequitazine—CYP3A4—prostate cancer	4.97e-05	0.0277	CrCbGaD
Perphenazine—Hyperglycaemia—Doxorubicin—prostate cancer	4.97e-05	0.000537	CcSEcCtD
Perphenazine—Diarrhoea—Mitoxantrone—prostate cancer	4.97e-05	0.000537	CcSEcCtD
Perphenazine—Dry mouth—Capecitabine—prostate cancer	4.96e-05	0.000536	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—prostate cancer	4.95e-05	0.000535	CcSEcCtD
Perphenazine—Shock—Docetaxel—prostate cancer	4.94e-05	0.000534	CcSEcCtD
Perphenazine—Domperidone—CYP3A4—prostate cancer	4.91e-05	0.0273	CrCbGaD
Perphenazine—Drowsiness—Doxorubicin—prostate cancer	4.91e-05	0.000531	CcSEcCtD
Perphenazine—Confusional state—Capecitabine—prostate cancer	4.9e-05	0.000529	CcSEcCtD
Perphenazine—Tachycardia—Docetaxel—prostate cancer	4.9e-05	0.000529	CcSEcCtD
Perphenazine—Headache—Estradiol—prostate cancer	4.88e-05	0.000528	CcSEcCtD
Perphenazine—Agitation—Prednisone—prostate cancer	4.87e-05	0.000527	CcSEcCtD
Perphenazine—Fluphenazine—CYP2E1—prostate cancer	4.85e-05	0.027	CrCbGaD
Perphenazine—Bradycardia—Epirubicin—prostate cancer	4.85e-05	0.000524	CcSEcCtD
Perphenazine—Angioedema—Prednisone—prostate cancer	4.84e-05	0.000524	CcSEcCtD
Perphenazine—Infection—Capecitabine—prostate cancer	4.83e-05	0.000522	CcSEcCtD
Perphenazine—Urticaria—Etoposide—prostate cancer	4.8e-05	0.000518	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—prostate cancer	4.79e-05	0.000517	CcSEcCtD
Perphenazine—Anorexia—Docetaxel—prostate cancer	4.78e-05	0.000517	CcSEcCtD
Perphenazine—Shock—Capecitabine—prostate cancer	4.78e-05	0.000517	CcSEcCtD
Perphenazine—Body temperature increased—Etoposide—prostate cancer	4.77e-05	0.000516	CcSEcCtD
Perphenazine—Syncope—Prednisone—prostate cancer	4.75e-05	0.000514	CcSEcCtD
Perphenazine—Tachycardia—Capecitabine—prostate cancer	4.74e-05	0.000512	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—prostate cancer	4.74e-05	0.000512	CcSEcCtD
Perphenazine—Oedema peripheral—Epirubicin—prostate cancer	4.69e-05	0.000507	CcSEcCtD
Perphenazine—Hypotension—Docetaxel—prostate cancer	4.69e-05	0.000507	CcSEcCtD
Perphenazine—Loss of consciousness—Prednisone—prostate cancer	4.66e-05	0.000504	CcSEcCtD
Perphenazine—Anorexia—Capecitabine—prostate cancer	4.63e-05	0.000501	CcSEcCtD
Perphenazine—Convulsion—Prednisone—prostate cancer	4.59e-05	0.000497	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—prostate cancer	4.58e-05	0.000495	CcSEcCtD
Perphenazine—Hypertension—Prednisone—prostate cancer	4.58e-05	0.000495	CcSEcCtD
Perphenazine—Headache—Mitoxantrone—prostate cancer	4.55e-05	0.000492	CcSEcCtD
Perphenazine—Hypotension—Capecitabine—prostate cancer	4.54e-05	0.000491	CcSEcCtD
Perphenazine—Insomnia—Docetaxel—prostate cancer	4.54e-05	0.000491	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—prostate cancer	4.49e-05	0.000485	CcSEcCtD
Perphenazine—Dyspnoea—Docetaxel—prostate cancer	4.47e-05	0.000484	CcSEcCtD
Perphenazine—Somnolence—Docetaxel—prostate cancer	4.46e-05	0.000482	CcSEcCtD
Perphenazine—Hypersensitivity—Etoposide—prostate cancer	4.45e-05	0.000481	CcSEcCtD
Perphenazine—Clomipramine—CYP2C19—prostate cancer	4.4e-05	0.0245	CrCbGaD
Perphenazine—Insomnia—Capecitabine—prostate cancer	4.39e-05	0.000475	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—prostate cancer	4.38e-05	0.000474	CcSEcCtD
Perphenazine—Decreased appetite—Docetaxel—prostate cancer	4.36e-05	0.000471	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—prostate cancer	4.34e-05	0.000469	CcSEcCtD
Perphenazine—Dyspnoea—Capecitabine—prostate cancer	4.33e-05	0.000468	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisone—prostate cancer	4.33e-05	0.000468	CcSEcCtD
Perphenazine—Infection—Prednisone—prostate cancer	4.3e-05	0.000465	CcSEcCtD
Perphenazine—Pain—Docetaxel—prostate cancer	4.29e-05	0.000464	CcSEcCtD
Perphenazine—Constipation—Docetaxel—prostate cancer	4.29e-05	0.000464	CcSEcCtD
Perphenazine—Pruritus—Etoposide—prostate cancer	4.27e-05	0.000462	CcSEcCtD
Perphenazine—Shock—Prednisone—prostate cancer	4.26e-05	0.00046	CcSEcCtD
Perphenazine—Tachycardia—Prednisone—prostate cancer	4.22e-05	0.000457	CcSEcCtD
Perphenazine—Decreased appetite—Capecitabine—prostate cancer	4.22e-05	0.000456	CcSEcCtD
Perphenazine—Thioridazine—CYP2E1—prostate cancer	4.18e-05	0.0233	CrCbGaD
Perphenazine—Pain—Capecitabine—prostate cancer	4.15e-05	0.000449	CcSEcCtD
Perphenazine—Constipation—Capecitabine—prostate cancer	4.15e-05	0.000449	CcSEcCtD
Perphenazine—Erythema—Epirubicin—prostate cancer	4.15e-05	0.000448	CcSEcCtD
Perphenazine—Thioridazine—CYP2C19—prostate cancer	4.14e-05	0.023	CrCbGaD
Perphenazine—Diarrhoea—Etoposide—prostate cancer	4.13e-05	0.000447	CcSEcCtD
Perphenazine—Anorexia—Prednisone—prostate cancer	4.12e-05	0.000446	CcSEcCtD
Perphenazine—Nefazodone—CYP3A4—prostate cancer	4.08e-05	0.0227	CrCbGaD
Perphenazine—Methotrimeprazine—CYP2E1—prostate cancer	3.99e-05	0.0222	CrCbGaD
Perphenazine—Dizziness—Etoposide—prostate cancer	3.99e-05	0.000432	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—prostate cancer	3.99e-05	0.000431	CcSEcCtD
Perphenazine—Body temperature increased—Docetaxel—prostate cancer	3.97e-05	0.000429	CcSEcCtD
Perphenazine—Insomnia—Prednisone—prostate cancer	3.91e-05	0.000423	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—prostate cancer	3.91e-05	0.000422	CcSEcCtD
Perphenazine—Urticaria—Capecitabine—prostate cancer	3.86e-05	0.000417	CcSEcCtD
Perphenazine—Body temperature increased—Capecitabine—prostate cancer	3.84e-05	0.000415	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—prostate cancer	3.84e-05	0.000415	CcSEcCtD
Perphenazine—Agitation—Epirubicin—prostate cancer	3.81e-05	0.000412	CcSEcCtD
Perphenazine—Aripiprazole—CYP3A4—prostate cancer	3.79e-05	0.0211	CrCbGaD
Perphenazine—Headache—Etoposide—prostate cancer	3.78e-05	0.000409	CcSEcCtD
Perphenazine—Trazodone—CYP3A4—prostate cancer	3.77e-05	0.021	CrCbGaD
Perphenazine—Decreased appetite—Prednisone—prostate cancer	3.76e-05	0.000407	CcSEcCtD
Perphenazine—Quetiapine—CYP2C19—prostate cancer	3.73e-05	0.0207	CrCbGaD
Perphenazine—Syncope—Epirubicin—prostate cancer	3.72e-05	0.000402	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—prostate cancer	3.71e-05	0.000401	CcSEcCtD
Perphenazine—Constipation—Prednisone—prostate cancer	3.7e-05	0.0004	CcSEcCtD
Perphenazine—Hypersensitivity—Docetaxel—prostate cancer	3.7e-05	0.0004	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—prostate cancer	3.69e-05	0.000399	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—prostate cancer	3.64e-05	0.000394	CcSEcCtD
Perphenazine—Cough—Epirubicin—prostate cancer	3.62e-05	0.000391	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—prostate cancer	3.62e-05	0.000391	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—prostate cancer	3.59e-05	0.000388	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—prostate cancer	3.58e-05	0.000387	CcSEcCtD
Perphenazine—Hypersensitivity—Capecitabine—prostate cancer	3.58e-05	0.000387	CcSEcCtD
Perphenazine—Pruritus—Docetaxel—prostate cancer	3.55e-05	0.000384	CcSEcCtD
Perphenazine—Pipotiazine—CYP3A4—prostate cancer	3.54e-05	0.0197	CrCbGaD
Perphenazine—Agitation—Doxorubicin—prostate cancer	3.53e-05	0.000381	CcSEcCtD
Perphenazine—Dry mouth—Epirubicin—prostate cancer	3.45e-05	0.000373	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—prostate cancer	3.44e-05	0.000372	CcSEcCtD
Perphenazine—Urticaria—Prednisone—prostate cancer	3.44e-05	0.000372	CcSEcCtD
Perphenazine—Pruritus—Capecitabine—prostate cancer	3.44e-05	0.000372	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—prostate cancer	3.43e-05	0.000371	CcSEcCtD
Perphenazine—Diarrhoea—Docetaxel—prostate cancer	3.43e-05	0.000371	CcSEcCtD
Perphenazine—Promazine—CYP2C19—prostate cancer	3.43e-05	0.0191	CrCbGaD
Perphenazine—Body temperature increased—Prednisone—prostate cancer	3.42e-05	0.00037	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—prostate cancer	3.41e-05	0.000369	CcSEcCtD
Perphenazine—Anaphylactic shock—Epirubicin—prostate cancer	3.38e-05	0.000366	CcSEcCtD
Perphenazine—Prochlorperazine—CYP3A4—prostate cancer	3.38e-05	0.0188	CrCbGaD
Perphenazine—Loss of consciousness—Doxorubicin—prostate cancer	3.37e-05	0.000365	CcSEcCtD
Perphenazine—Infection—Epirubicin—prostate cancer	3.36e-05	0.000363	CcSEcCtD
Perphenazine—Cough—Doxorubicin—prostate cancer	3.35e-05	0.000362	CcSEcCtD
Perphenazine—Shock—Epirubicin—prostate cancer	3.33e-05	0.00036	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—prostate cancer	3.32e-05	0.000359	CcSEcCtD
Perphenazine—Diarrhoea—Capecitabine—prostate cancer	3.32e-05	0.000359	CcSEcCtD
Perphenazine—Dizziness—Docetaxel—prostate cancer	3.32e-05	0.000359	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—prostate cancer	3.31e-05	0.000358	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—prostate cancer	3.3e-05	0.000357	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—prostate cancer	3.23e-05	0.000349	CcSEcCtD
Perphenazine—Dizziness—Capecitabine—prostate cancer	3.21e-05	0.000347	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—prostate cancer	3.19e-05	0.000345	CcSEcCtD
Perphenazine—Hypersensitivity—Prednisone—prostate cancer	3.19e-05	0.000345	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—prostate cancer	3.16e-05	0.000342	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—prostate cancer	3.16e-05	0.000341	CcSEcCtD
Perphenazine—Headache—Docetaxel—prostate cancer	3.14e-05	0.00034	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—prostate cancer	3.13e-05	0.000338	CcSEcCtD
Perphenazine—Infection—Doxorubicin—prostate cancer	3.11e-05	0.000336	CcSEcCtD
Perphenazine—Shock—Doxorubicin—prostate cancer	3.08e-05	0.000333	CcSEcCtD
Perphenazine—Pruritus—Prednisone—prostate cancer	3.06e-05	0.000331	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—prostate cancer	3.06e-05	0.000331	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—prostate cancer	3.06e-05	0.00033	CcSEcCtD
Perphenazine—Chlorpromazine—CYP2E1—prostate cancer	3.04e-05	0.0169	CrCbGaD
Perphenazine—Headache—Capecitabine—prostate cancer	3.04e-05	0.000329	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—prostate cancer	3.02e-05	0.000326	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—prostate cancer	3.01e-05	0.000325	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—prostate cancer	2.98e-05	0.000323	CcSEcCtD
Perphenazine—Diarrhoea—Prednisone—prostate cancer	2.96e-05	0.00032	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—prostate cancer	2.94e-05	0.000318	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—prostate cancer	2.93e-05	0.000316	CcSEcCtD
Perphenazine—Constipation—Epirubicin—prostate cancer	2.89e-05	0.000313	CcSEcCtD
Perphenazine—Pain—Epirubicin—prostate cancer	2.89e-05	0.000313	CcSEcCtD
Perphenazine—Dizziness—Prednisone—prostate cancer	2.86e-05	0.000309	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—prostate cancer	2.83e-05	0.000306	CcSEcCtD
Perphenazine—Clomipramine—CYP3A4—prostate cancer	2.8e-05	0.0156	CrCbGaD
Perphenazine—Dyspnoea—Doxorubicin—prostate cancer	2.79e-05	0.000302	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—prostate cancer	2.78e-05	0.000301	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—prostate cancer	2.72e-05	0.000294	CcSEcCtD
Perphenazine—Headache—Prednisone—prostate cancer	2.71e-05	0.000293	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—prostate cancer	2.69e-05	0.000291	CcSEcCtD
Perphenazine—Pain—Doxorubicin—prostate cancer	2.68e-05	0.000289	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—prostate cancer	2.68e-05	0.000289	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—prostate cancer	2.67e-05	0.000289	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—prostate cancer	2.49e-05	0.00027	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—prostate cancer	2.49e-05	0.000269	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—prostate cancer	2.48e-05	0.000268	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—prostate cancer	2.39e-05	0.000259	CcSEcCtD
Perphenazine—Quetiapine—CYP3A4—prostate cancer	2.37e-05	0.0132	CrCbGaD
Perphenazine—Diarrhoea—Epirubicin—prostate cancer	2.32e-05	0.00025	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—prostate cancer	2.31e-05	0.000249	CcSEcCtD
Perphenazine—Dizziness—Epirubicin—prostate cancer	2.24e-05	0.000242	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—prostate cancer	2.22e-05	0.000239	CcSEcCtD
Perphenazine—Promazine—CYP3A4—prostate cancer	2.18e-05	0.0121	CrCbGaD
Perphenazine—Diarrhoea—Doxorubicin—prostate cancer	2.14e-05	0.000232	CcSEcCtD
Perphenazine—Headache—Epirubicin—prostate cancer	2.12e-05	0.000229	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—prostate cancer	2.07e-05	0.000224	CcSEcCtD
Perphenazine—Headache—Doxorubicin—prostate cancer	1.96e-05	0.000212	CcSEcCtD
Perphenazine—Chlorpromazine—CYP3A4—prostate cancer	1.92e-05	0.0107	CrCbGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	6.59e-07	6.19e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PIK3CA—prostate cancer	6.59e-07	6.18e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PIK3CA—prostate cancer	6.59e-07	6.18e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—prostate cancer	6.57e-07	6.17e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MDM2—prostate cancer	6.56e-07	6.16e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MDM2—prostate cancer	6.56e-07	6.16e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	6.56e-07	6.16e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—TYMS—prostate cancer	6.55e-07	6.15e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—prostate cancer	6.55e-07	6.15e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—prostate cancer	6.55e-07	6.15e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EP300—prostate cancer	6.55e-07	6.15e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—prostate cancer	6.54e-07	6.14e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—prostate cancer	6.54e-07	6.14e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EP300—prostate cancer	6.53e-07	6.14e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.53e-07	6.14e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—prostate cancer	6.53e-07	6.13e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—prostate cancer	6.53e-07	6.13e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—prostate cancer	6.52e-07	6.12e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—EP300—prostate cancer	6.5e-07	6.11e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTM1—prostate cancer	6.47e-07	6.08e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	6.47e-07	6.08e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—SRC—prostate cancer	6.47e-07	6.08e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ERBB2—prostate cancer	6.47e-07	6.07e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ERBB2—prostate cancer	6.47e-07	6.07e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CD—prostate cancer	6.46e-07	6.07e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—prostate cancer	6.46e-07	6.07e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—prostate cancer	6.43e-07	6.04e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	6.41e-07	6.02e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CD—prostate cancer	6.41e-07	6.02e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—prostate cancer	6.4e-07	6.01e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—prostate cancer	6.4e-07	6.01e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CB—prostate cancer	6.38e-07	5.99e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CB—prostate cancer	6.38e-07	5.99e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—SRC—prostate cancer	6.37e-07	5.98e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—LPL—prostate cancer	6.35e-07	5.97e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—SRC—prostate cancer	6.35e-07	5.97e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—prostate cancer	6.34e-07	5.95e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—prostate cancer	6.31e-07	5.92e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—prostate cancer	6.3e-07	5.92e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—EP300—prostate cancer	6.29e-07	5.91e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—EP300—prostate cancer	6.29e-07	5.91e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	6.28e-07	5.9e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	6.26e-07	5.88e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—prostate cancer	6.25e-07	5.87e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	6.25e-07	5.87e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STAT3—prostate cancer	6.24e-07	5.86e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CG—prostate cancer	6.23e-07	5.85e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—prostate cancer	6.22e-07	5.84e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—prostate cancer	6.2e-07	5.82e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1B—prostate cancer	6.19e-07	5.81e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—prostate cancer	6.19e-07	5.81e-06	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—prostate cancer	6.19e-07	5.81e-06	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—prostate cancer	6.18e-07	5.8e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STAT3—prostate cancer	6.14e-07	5.77e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.14e-07	5.76e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—prostate cancer	6.13e-07	5.76e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—prostate cancer	6.13e-07	5.76e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STAT3—prostate cancer	6.13e-07	5.75e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CB—prostate cancer	6.13e-07	5.75e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—NOS3—prostate cancer	6.1e-07	5.73e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—prostate cancer	6.1e-07	5.73e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	6.09e-07	5.72e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ERCC2—prostate cancer	6.09e-07	5.72e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—prostate cancer	6.07e-07	5.7e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—prostate cancer	6.07e-07	5.7e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—prostate cancer	6.07e-07	5.7e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—prostate cancer	6.06e-07	5.69e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—NOS3—prostate cancer	6.05e-07	5.68e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—prostate cancer	6.05e-07	5.68e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—prostate cancer	6.05e-07	5.68e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—prostate cancer	6.03e-07	5.66e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—prostate cancer	6.02e-07	5.65e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—prostate cancer	6.02e-07	5.65e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1B—prostate cancer	5.99e-07	5.62e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1B—prostate cancer	5.99e-07	5.62e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EP300—prostate cancer	5.96e-07	5.59e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTEN—prostate cancer	5.93e-07	5.57e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—prostate cancer	5.91e-07	5.55e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—INS—prostate cancer	5.9e-07	5.54e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—prostate cancer	5.87e-07	5.51e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—prostate cancer	5.87e-07	5.51e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—prostate cancer	5.86e-07	5.5e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—prostate cancer	5.86e-07	5.5e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CTNNB1—prostate cancer	5.85e-07	5.49e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—prostate cancer	5.83e-07	5.48e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—prostate cancer	5.83e-07	5.48e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—prostate cancer	5.8e-07	5.45e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SRC—prostate cancer	5.79e-07	5.44e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—prostate cancer	5.79e-07	5.43e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CREBBP—prostate cancer	5.78e-07	5.42e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—prostate cancer	5.77e-07	5.42e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—prostate cancer	5.74e-07	5.39e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—prostate cancer	5.73e-07	5.38e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MTHFR—prostate cancer	5.72e-07	5.37e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1A—prostate cancer	5.71e-07	5.36e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—prostate cancer	5.71e-07	5.36e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—prostate cancer	5.71e-07	5.36e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—prostate cancer	5.71e-07	5.36e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTEN—prostate cancer	5.7e-07	5.35e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—prostate cancer	5.69e-07	5.35e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—prostate cancer	5.69e-07	5.35e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—prostate cancer	5.68e-07	5.33e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—prostate cancer	5.67e-07	5.33e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CTNNB1—prostate cancer	5.66e-07	5.31e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CTNNB1—prostate cancer	5.66e-07	5.31e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—EP300—prostate cancer	5.66e-07	5.31e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	5.64e-07	5.3e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CB—prostate cancer	5.63e-07	5.29e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARA—prostate cancer	5.61e-07	5.27e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	5.61e-07	5.27e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	5.59e-07	5.25e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.59e-07	5.24e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—prostate cancer	5.58e-07	5.24e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—prostate cancer	5.58e-07	5.24e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	5.58e-07	5.24e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—prostate cancer	5.57e-07	5.23e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—prostate cancer	5.56e-07	5.22e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—prostate cancer	5.56e-07	5.22e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—prostate cancer	5.56e-07	5.22e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—prostate cancer	5.55e-07	5.21e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—prostate cancer	5.55e-07	5.21e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—prostate cancer	5.53e-07	5.2e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1A—prostate cancer	5.53e-07	5.19e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1A—prostate cancer	5.53e-07	5.19e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTEN—prostate cancer	5.51e-07	5.18e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTEN—prostate cancer	5.51e-07	5.18e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—prostate cancer	5.51e-07	5.17e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CD—prostate cancer	5.48e-07	5.14e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EP300—prostate cancer	5.44e-07	5.1e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—prostate cancer	5.42e-07	5.09e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—prostate cancer	5.4e-07	5.07e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—prostate cancer	5.38e-07	5.05e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—prostate cancer	5.38e-07	5.05e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—prostate cancer	5.36e-07	5.03e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—prostate cancer	5.33e-07	5e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—prostate cancer	5.33e-07	5e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—prostate cancer	5.33e-07	5e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTEN—prostate cancer	5.29e-07	4.97e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SRC—prostate cancer	5.29e-07	4.96e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CAV1—prostate cancer	5.28e-07	4.96e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—prostate cancer	5.27e-07	4.95e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—prostate cancer	5.27e-07	4.95e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—prostate cancer	5.26e-07	4.94e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EP300—prostate cancer	5.26e-07	4.94e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EP300—prostate cancer	5.26e-07	4.94e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—prostate cancer	5.19e-07	4.88e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	5.18e-07	4.86e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—NOS3—prostate cancer	5.17e-07	4.86e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—prostate cancer	5.15e-07	4.83e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SRC—prostate cancer	5.11e-07	4.8e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SRC—prostate cancer	5.11e-07	4.8e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STAT3—prostate cancer	5.1e-07	4.79e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—prostate cancer	5.09e-07	4.78e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—prostate cancer	5.08e-07	4.77e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	5.08e-07	4.77e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—EP300—prostate cancer	5.05e-07	4.74e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—prostate cancer	4.98e-07	4.68e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—prostate cancer	4.98e-07	4.68e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—prostate cancer	4.97e-07	4.66e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—prostate cancer	4.94e-07	4.64e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—prostate cancer	4.94e-07	4.64e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STAT3—prostate cancer	4.93e-07	4.63e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STAT3—prostate cancer	4.93e-07	4.63e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	4.92e-07	4.62e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—prostate cancer	4.92e-07	4.62e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—prostate cancer	4.92e-07	4.62e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—prostate cancer	4.92e-07	4.62e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—prostate cancer	4.92e-07	4.62e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTEN—prostate cancer	4.87e-07	4.57e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	4.84e-07	4.55e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	4.83e-07	4.54e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTEN—prostate cancer	4.83e-07	4.53e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—prostate cancer	4.81e-07	4.52e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.81e-07	4.51e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	4.8e-07	4.5e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CB—prostate cancer	4.77e-07	4.48e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—prostate cancer	4.76e-07	4.47e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—prostate cancer	4.74e-07	4.45e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—prostate cancer	4.73e-07	4.44e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—prostate cancer	4.73e-07	4.44e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—prostate cancer	4.69e-07	4.41e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—prostate cancer	4.69e-07	4.4e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—prostate cancer	4.68e-07	4.39e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—prostate cancer	4.65e-07	4.37e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—prostate cancer	4.65e-07	4.37e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—EP300—prostate cancer	4.64e-07	4.36e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—prostate cancer	4.63e-07	4.35e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—EP300—prostate cancer	4.6e-07	4.32e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—prostate cancer	4.58e-07	4.3e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—prostate cancer	4.58e-07	4.3e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—prostate cancer	4.58e-07	4.3e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—prostate cancer	4.57e-07	4.29e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—prostate cancer	4.57e-07	4.29e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—prostate cancer	4.56e-07	4.28e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—INS—prostate cancer	4.55e-07	4.27e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—prostate cancer	4.54e-07	4.26e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—prostate cancer	4.54e-07	4.26e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—prostate cancer	4.48e-07	4.21e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—prostate cancer	4.48e-07	4.21e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CREBBP—prostate cancer	4.46e-07	4.19e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	4.41e-07	4.14e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—prostate cancer	4.38e-07	4.11e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—prostate cancer	4.36e-07	4.09e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—prostate cancer	4.31e-07	4.04e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—prostate cancer	4.29e-07	4.03e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—prostate cancer	4.28e-07	4.02e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—prostate cancer	4.26e-07	4e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—prostate cancer	4.23e-07	3.98e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—prostate cancer	4.23e-07	3.98e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.23e-07	3.97e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.18e-07	3.93e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTEN—prostate cancer	4.12e-07	3.87e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—prostate cancer	4.04e-07	3.79e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—prostate cancer	4.02e-07	3.78e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—prostate cancer	4.02e-07	3.78e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—NOS3—prostate cancer	3.99e-07	3.75e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—prostate cancer	3.96e-07	3.72e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—prostate cancer	3.95e-07	3.71e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—EP300—prostate cancer	3.93e-07	3.69e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—prostate cancer	3.93e-07	3.69e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—prostate cancer	3.9e-07	3.66e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—prostate cancer	3.89e-07	3.65e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—prostate cancer	3.89e-07	3.65e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—prostate cancer	3.89e-07	3.65e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—prostate cancer	3.8e-07	3.57e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—prostate cancer	3.8e-07	3.57e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—prostate cancer	3.76e-07	3.53e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—prostate cancer	3.76e-07	3.53e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.73e-07	3.51e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.68e-07	3.46e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—prostate cancer	3.65e-07	3.43e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	3.6e-07	3.38e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—prostate cancer	3.56e-07	3.34e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—prostate cancer	3.44e-07	3.23e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—prostate cancer	3.44e-07	3.23e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.43e-07	3.23e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—prostate cancer	3.42e-07	3.21e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.4e-07	3.2e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—prostate cancer	3.29e-07	3.08e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTEN—prostate cancer	3.18e-07	2.99e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—prostate cancer	3.18e-07	2.98e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—prostate cancer	3.18e-07	2.98e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—prostate cancer	3.05e-07	2.86e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—EP300—prostate cancer	3.04e-07	2.85e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—prostate cancer	2.91e-07	2.73e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—prostate cancer	2.81e-07	2.63e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—prostate cancer	2.78e-07	2.61e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—prostate cancer	2.38e-07	2.23e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.25e-07	2.11e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—prostate cancer	1.83e-07	1.72e-06	CbGpPWpGaD
